Boris L. Zaïtra

Head of Corporate Business Development (Member of the enlarged CEC since 2024)

About Roche

Zur deutschen Version

Personal Data

Nationality
France

Year of Birth
1972

Education

1995
Ecole Polytechnique (X92), France, Engineering, M.Sc.)

2009
Harvard Business School, Advanced Management Programme (AMP 177)

Professional experience

1995–1999
JP Morgan, Mergers & Acquisitions, Associate

1999–2005
Duke Street Capital, Partner

2005–2012
Airbus Group, Head of Mergers & Acquisitions, Corporate Vice-President

2012–2024
Roche Basel, Head of Group Business Development / M&A

Since 2024
Roche Basel, Head of Corporate Business Development

Present external mandates

–

Other activities / non-profit activities / memberships

Since 2018
Non-Executive Director at Stiftung Lohnhof, Basel

Since 2025
Member of the Board of Directors, Chugai Pharmaceutical Co., Ltd

Awards / Honors

–

Möchten Sie den Inhalt auf Deutsch lesen?

Zur deutschen Version

Discover more

Board of DirectorsAbout Roche

The Board of Directors' composition and the curricula vitae of its members.

Executive CommitteeAbout Roche

The Executive Committee's composition and the curricula vitae of its members.

Annual General MeetingAbout Roche

The General Meeting is convened by the Board of Directors, together with its agenda and the proposals of the Board of Directors and the shareholders.

Board CommitteesAbout Roche

Our Board of Directors has delegated certain matters to four committees for detailed attention.

Code of conductAbout Roche

The Roche Group Code of Conduct states the expectations Roche as an employer has towards his employees and sets forth the standards for business behaviour that apply throughout the Roche Group.

InvestorsInvestors

We are committed to delivering value for all our stakeholders through continuous innovation, groundbreaking solutions, trust and sustainable business practices.